Announcements Archives - Page 7 of 30 - PMWC Precision Medicine World Conference

Top Header Mobile

Updates

Contact

Agenda

14 Sep

Will the Benefits of Personalized Cardiovascular Medicine Outpace the Expected 23.6 Million Deaths by the Next Decade?

With the dawn of DNA sequencing, wearable technologies, and big data applications such as artificial intelligence and machine learning, detailed characterization of human biology and behaviors is now possible at an unprecedented scale. This is reflected in the rise of global population studies, creating opportunities...

04:13 / Announcements

0 Likes

14 Sep

An Interview with Xing-Jian Lou, NHI/NCI

Q: What is your responsibility when selecting and/or working with these early stage companies? A: NCI SBIR Program Directors do not play a role in reviewing the SBIR/STTR applications. That process is done at the NIH Peer Review panel....

04:12 / Announcements / Q&A / Speaker spotlights

0 Likes

14 Sep

An Interview with Joshua Schiffman, PEEL Therapeutics, Inc.

Q: There are various new, emerging therapeutics that bring us closer towards a cure for life-threatening disorders such as cancer, HIV, or Huntington’s disease. Prominent examples include the popular gene editing tool CRISPR or new and improved cell and gene therapies. By when can we...

04:11 / Announcements / Q&A / Speaker spotlights

0 Likes

14 Sep

Population Studies: Enabling Individualized Disease Treatment, Care, and Prevention

04:10 / Announcements

0 Likes

14 Sep

An Interview with Somalee Datta, Stanford Medicine

Q: Your current focus is on creating a large-scale biomedical data analytics platform, a “data lake” that aggregates and provides access to various types of data, including EMR, omics, clinical data, ECG, imaging, population health, and wearable devices data and is linked for analytical access...

04:09 / Announcements / Q&A / Speaker spotlights

0 Likes

14 Sep

An Interview with Justin Kao, Helix

Q: Helix is involved in a number of major population initiatives that have recently been launched. can you tell us more about these initiatives - what are their goals and what is Helix’s role? A: We are proud to work with health systems across the US...

04:08 / Announcements / Q&A / Speaker spotlights

0 Likes

14 Sep

Closing Research Gaps and Eliminating Bias in Women and Minority Health: It’s Good for Your Health

Gender bias and minority health in our medical system can have serious and sometimes fatal repercussions. These inequalities are now being addressed with intensive and collaborative efforts at all levels of research and in the clinical setting....

04:07 / Announcements

0 Likes

14 Sep

Q&A with Vicki Ellingrod, University of Michigan

Q: The prevalence of metabolic syndrome in patients with schizophrenia is much higher compared to the general population. What is the role of folate pharmacogenomics on inflammatory and metabolic complications from atypical antipsychotic use in schizophrenia? A: The folate hypothesis of schizophrenia is an emerging field...

04:06 / Announcements / Q&A / Speaker spotlights

0 Likes

14 Sep

Q&A with Ellen Matloff, My Gene Counsel

Q: Cancer Genomic Profiling is being used more routinely as standard of care in many cancer types. To date, it has been used to determine what therapies are most likely to work on that tumor, prognosis for that patient, and to uncover clinical trial...

04:05 / Announcements / Q&A / Speaker spotlights

0 Likes

14 Sep

Q&A with Edward Kim, Atrium Health

Q: Interpreting data at the point of care has its challenges, especially when it comes to integrating the various types of data for combined analysis and clinical applications (e.g. clinical, imaging, and genomics data). What are some of the challenges the industry is facing and...

04:04 / Announcements / Q&A / Speaker spotlights

0 Likes

Will the Benefits of Personalized Cardiovascular Medicine Outpace the Expected 23.6 Million Deaths by the Next Decade?

An Interview with Xing-Jian Lou, NHI/NCI

An Interview with Joshua Schiffman, PEEL Therapeutics, Inc.

Population Studies: Enabling Individualized Disease Treatment, Care, and Prevention

An Interview with Somalee Datta, Stanford Medicine

An Interview with Justin Kao, Helix

Closing Research Gaps and Eliminating Bias in Women and Minority Health: It’s Good for Your Health

Q&A with Vicki Ellingrod, University of Michigan

Q&A with Ellen Matloff, My Gene Counsel

Q&A with Edward Kim, Atrium Health

Sign up for occasional updates on upcoming conferences, news, and other information.

Get Updates:

Sign up for occasional updates on upcoming conferences, news, and other information.

Get Updates: